HighTower Advisors’s CVS Health CVS Stock Holding History

HighTower Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,600	Closed	-$5.75K	–	3801
2025 Q1	$5.75K	Sell	1,600 -1,000	-38%	-$59.8K	﹤0.01%	3577
2024 Q4	$3.25K	Buy	+2,600	New	+$146K	﹤0.01%	3653
2024 Q3	–	Sell	-800	Closed	-$2.11K	–	3796
2024 Q2	$2.11K	Buy	+800	New	+$50K	﹤0.01%	3527
2023 Q2	–	Sell	-3,000	Closed	-$3.36K	–	3488
2023 Q1	$3.36K	Buy	+3,000	New	+$252K	﹤0.01%	3260
2020 Q4	–	Sell	-17,000	Closed	-$33K	–	2645
2020 Q3	$33K	Buy	+17,000	New	+$1.06M	﹤0.01%	2329
2019 Q2	–	Sell	-5,800	Closed	-$2K	–	2405
2019 Q1	$2K	Buy	+5,800	New	+$358K	﹤0.01%	2250

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

HighTower Advisors's CVS Position: Q2 2026 in Review

HighTower Advisors reduced its CVS Health (CVS) stake by 0.65% in Q2 2026, selling an estimated $212K and leaving 360,179 shares worth $37.3M. The position accounts for 0.04% of the portfolio, ranked #458.

HighTower Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $128M in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

HighTower Advisors held 360,179 shares of CVS Health worth $37.3M as of Q2 2026.
HighTower Advisors sold 2,371 CVS Health shares in Q2 2026, an estimated $212K.
CVS Health made up 0.04% of HighTower Advisors's portfolio in Q2 2026, its #458 holding.
HighTower Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
HighTower Advisors's CVS Health position peaked at $128M in Q4 2021.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.